跳至主要内容
临床试验/NCT04204954
NCT04204954已完成2 期

A Randomized Controlled Trial of Treatment Efficacy in Ameliorating Demodex Spp. Infestation Among Cases Undergoing Cataract Surgery

Hospital de La Luz1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2019年5月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
160
试验地点
1
主要终点
Mean Demodex spp. infestation index by intervention group

研究概览

简要总结

Demodex blepharitis is a prevalent cause of comorbid infection among individuals undergoing cataract surgery. Several complications may arise in the postsurgical period from Staphylococcus or Streptococcus co-infections, as Demodex is a vector for these pathogens. Hence, prophylactic treatments before cataract surgery may lead to a reduction in complication rates. Since Demodex infestation and cataract surgery are two prevalent coexisting conditions in the general population, this study aims to test the effect of four combined treatments to eradicate or improve the Demodex infestation index before surgery. The investigators are conducting a single-blinded randomized trial of four therapies in participants undergoing cataract surgery. All participants will or are receiving daily eyelid cleansing bid and topical 0.3% ciprofloxacin q4h for three days added to the allocated treatment arm. Our four intervention groups are: [1] Blephaclean eye scrubs; [2] 50% dilution baby shampoo; [3] tea tree oil shampoo; [4]: topical 0.3% ciprofloxacin alone. To assess treatment efficacy, the investigators will perform eyelash hair epilation pre and postoperatively. The primary outcome is a change in the mean Demodex spp. infestation index. Also, a change in the crude number of Demodex (egg, larvae, nymph, or adult-form) spp. in eyelashes after one-week of therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

Investigators and outcomes assessors were blinded to the treatment allocation of each participant. Outcome assessors were anterior segment surgeons who evaluated cases prior to cataract surgery. There was no indication of group allocation in the electronic medical records (EMR), only the participation of each candidate in the study. Similarly, investigators were blinded to group allocation and only recorded data directly from EMR. Blinding was kept after data analysis.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent after explanation of the nature and possible consequences of the study.
  • Clinical diagnosis of cataracts staged with Lens Opacity Classification System III based on the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery guidelines.
  • No topical antibiotic ointment therapy or eyelid cleansing in the past six months.
  • No systemic antibiotic or antiparasite treatment in the past six months.
  • No ocular comorbidities (other than cataracts)
  • No systemic comorbidities.

排除标准

  • Withdrawal from the study.
  • Minimal changes based on the Lens Opacity Classification System III.

研究组 & 干预措施

Group 1: Topical 0.3% Ciprofloxacin [Cipro]

Other

Ciprofloxacin Ophthalmic Ointment 0.3% every four hours for three days.

干预措施: Ciprofloxacin Ophthalmic Ointment 0.3% (Drug)

Group 2: Cipro + 50% diluted baby shampoo

Active Comparator

Ciprofloxacin Ophthalmic Ointment 0.3% every four hours for three days. Twice a day eyelid margin cleansing with 50% diluted baby shampoo for three days.

干预措施: Ciprofloxacin Ophthalmic Ointment 0.3% (Drug)

Group 2: Cipro + 50% diluted baby shampoo

Active Comparator

Ciprofloxacin Ophthalmic Ointment 0.3% every four hours for three days. Twice a day eyelid margin cleansing with 50% diluted baby shampoo for three days.

干预措施: Baby shampoo (Other)

Group 3: Cipro + Blephaclean

Active Comparator

Ciprofloxacin Ophthalmic Ointment 0.3% every four hours for three days. Twice a day eyelid margin cleansing with Blephaclean Sterile Eyelid Wipes (Thea Pharmaceuticals) for three days.

干预措施: Ciprofloxacin Ophthalmic Ointment 0.3% (Drug)

Group 3: Cipro + Blephaclean

Active Comparator

Ciprofloxacin Ophthalmic Ointment 0.3% every four hours for three days. Twice a day eyelid margin cleansing with Blephaclean Sterile Eyelid Wipes (Thea Pharmaceuticals) for three days.

干预措施: Blephaclean (Other)

Group 4: Cipro + Tea tree oil.

Experimental

Ciprofloxacin Ophthalmic Ointment 0.3% every four hours for three days. Twice a day eyelid margin cleansing with tea tree oil shampoo for three days.

干预措施: Tea Tree Oil Shampoo (Other)

Group 4: Cipro + Tea tree oil.

Experimental

Ciprofloxacin Ophthalmic Ointment 0.3% every four hours for three days. Twice a day eyelid margin cleansing with tea tree oil shampoo for three days.

干预措施: Ciprofloxacin Ophthalmic Ointment 0.3% (Drug)

结局指标

主要结局

Mean Demodex spp. infestation index by intervention group

时间窗: One week.

Number of demodex (egg, larvae, nymph, adult-form) spp. per eyelash (taken from epilation).

Crude count of Demodex spp. adult-forms (mites) in eyelashes by intervention group

时间窗: One week.

Number of demodex (egg, larvae, nymph, adult-form) spp. in total (taken from epilation).

次要结局

  • Endophthalmitis in the postoperative period.(One week.)

研究者

发起方
Hospital de La Luz
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andric C Perez-Ortiz, M.D., M.P.H.

Clinical Professor

Hospital de La Luz

研究点 (1)

Loading locations...

相似试验